医学
血管紧张素受体阻滞剂
血管紧张素转换酶
肾脏疾病
药理学
血管紧张素受体
肾素-血管紧张素系统
血管紧张素II
疾病
肾
内科学
受体
内分泌学
血压
作者
Elaine Ku,Lesley A. Inker,Hocine Tighiouart,Charles E. McCulloch,Ogechi M. Adingwupu,Tom Greene,Raymond O. Estacio,Mark Woodward,Dick de Zeeuw,Julia B. Lewis,Thierry Hannedouche,Tazeen H. Jafar,Enyu Imai,Giuseppe Remuzzi,Hiddo J.L. Heerspink,Fan Fan Hou,Robert D. Toto,Philip Kam‐Tao Li,Mark J. Sarnak
摘要
In patients with advanced chronic kidney disease (CKD), the effects of initiating treatment with an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) on the risk for kidney failure with replacement therapy (KFRT) and death remain unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI